In situ analysis of transforming growth factors-β(TGF-β1, TGG-β2, TGF-β3) and TGF–β type II receptor expression in basal cell carcinomas
- 1 June 1996
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 134 (6), 1044-1051
- https://doi.org/10.1111/j.1365-2133.1996.tb07940.x
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Transforming growth factor beta: the good, the bad, and the ugly.The Journal of Experimental Medicine, 1994
- Mechanism of activation of the TGF-β receptorNature, 1994
- TGF-β1 Stimulates Expression of Keratinocyte Integrins During Re-Epithelialization of Cutaneous WoundsJournal of Investigative Dermatology, 1994
- TGF‐βS and TGF‐β type II receptor in human epidermis: Differential expression in acute and chronic skin woundsThe Journal of Pathology, 1993
- Injury Induced Expression of TGF-β1 mRNA Is Enhanced by Exogenously Applied TGF-βSBiochemical and Biophysical Research Communications, 1993
- Transforming growth factor-β distribution in basal cell carcinomas: relationship to proliferation indexBritish Journal of Dermatology, 1993
- Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblastsThe Journal of cell biology, 1993
- Intralesional interferon alfa-2b in the treatment of basal cell carcinoma: Immunohistochemical study on cellular immune reaction leading to tumor regressionJournal of the American Academy of Dermatology, 1991
- TREATMENT OF LARGE BASAL-CELL CARCINOMAS WITH INTRALESIONAL INTERFERON-ALPHA-2aThe Lancet, 1988
- Role of Transforming Growth Factor Beta in the Maturation of Human Epidermal KeratinocytesJournal of Investigative Dermatology, 1988